Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.56%373.67B | 9.35%1.45T | 9.77%360.81B | 6.80%1.33T | 5.63%336.5B | 5.98%335.74B | 6.32%326.18B | 9.40%328.7B | 17.13%1.24T | 13.49%318.57B |
| Cost of revenue | 3.80%287.21B | 9.08%1.12T | 9.11%276.7B | 6.79%1.03T | 4.33%259.69B | 6.65%260.03B | 6.56%252.64B | 9.82%253.6B | 17.16%960.75B | 14.89%248.91B |
| Gross profit | 2.80%86.46B | 10.28%332.13B | 11.99%84.11B | 6.85%301.16B | 10.25%76.8B | 3.76%75.71B | 5.52%73.54B | 8.00%75.1B | 17.03%281.86B | 8.74%69.66B |
| Operating expense | 5.84%71.06B | 10.28%274.7B | 11.12%67.14B | 4.18%249.1B | -6.02%65.66B | -4.58%61.17B | 16.60%61.84B | 15.98%60.43B | 24.09%239.11B | 23.15%69.86B |
| Selling and administrative expenses | 6.25%71.06B | 10.82%274.15B | 9.84%66.88B | 9.72%247.4B | -3.02%63.25B | 11.54%61.56B | 16.50%61.7B | 16.84%60.89B | --225.48B | --65.22B |
| -General and administrative expense | 6.25%71.06B | 10.82%274.15B | 9.84%66.88B | 9.72%247.4B | -3.02%63.25B | 11.54%61.56B | 16.50%61.7B | 16.84%60.89B | --225.48B | --65.22B |
| Other operating expenses | -51.39%157M | -58.72%1.35B | 476.79%323M | -76.40%3.28B | -36.30%2.99B | -99.59%37M | 17.90%191M | 5.66%56M | --13.89B | --4.7B |
| Total other operating income | 154.24%150M | -48.99%805M | -88.59%59M | 502.29%1.58B | 948.21%587M | 651.79%421M | -39.08%53M | 720.63%517M | --262M | --56M |
| Operating profit | -9.24%15.4B | 10.30%57.43B | 15.61%16.97B | 21.78%52.07B | 5,644.28%11.14B | 64.07%14.54B | -29.73%11.7B | -15.83%14.68B | -11.19%42.75B | -102.74%-201M |
| Net non-operating interest income (expenses) | -164.45%-301M | 201.85%385M | 636.78%467M | 62.16%-378M | 71.79%-90M | 95.36%-24M | 9.28%-176M | -380.65%-87M | -352.04%-999M | -564.58%-319M |
| Non-operating interest income | -82.22%152M | 134.10%2.15B | 114.29%855M | 61.05%918M | -30.50%180M | 422.81%298M | 0.00%103M | 24.30%399M | 1,063.27%570M | 1,338.89%259M |
| Non-operating interest expense | 16.75%453M | 36.11%1.76B | -20.16%388M | -17.40%1.3B | -53.29%270M | -43.90%322M | -6.06%279M | 67.59%486M | 481.11%1.57B | 775.76%578M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 184.00%168M | -5.83%-654M | -766.67%-200M | -22.38%-618M | -32.33%-307M | 46.88%-179M | -871.43%-162M | -30.23%30M | -190.23%-505M | 10.08%-232M |
| Special income (charges) | 0 | -2.14B | 0 | |||||||
| Less:Write off | ---- | --0 | ---- | --2.14B | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -11.39%15.27B | 16.82%57.16B | 17.89%17.23B | 18.61%48.93B | 1,244.15%8.6B | 79.04%14.34B | -31.05%11.37B | -16.52%14.62B | -17.57%41.25B | -109.10%-752M |
| Income tax | 8.94%4.24B | 14.75%19.45B | -20.32%3.89B | 2.92%16.95B | 2,626.40%3.16B | -3.84%5.39B | -31.27%3.52B | -16.80%4.88B | 8.17%16.47B | 76.68%-125M |
| Net income | -17.33%11.03B | 17.92%37.7B | 37.06%13.34B | 29.05%31.97B | 967.20%5.45B | 272.25%8.95B | -30.95%7.84B | -16.38%9.73B | -28.83%24.78B | -107.14%-628M |
| Net income continuous operations | -17.32%11.03B | 17.92%37.7B | 37.06%13.34B | 29.04%31.97B | 968.58%5.45B | 272.14%8.95B | -30.94%7.84B | -16.38%9.73B | -28.83%24.78B | -107.13%-627M |
| Noncontrolling interests | -5.91%366M | -8.54%1.83B | 6.58%389M | -0.65%2B | 62.09%684M | -17.80%508M | -6.13%444M | -27.15%365M | -30.73%2.02B | -46.85%422M |
| Net income attributable to the company | -17.68%10.66B | 19.69%35.87B | 38.24%12.95B | 31.68%29.97B | 553.09%4.76B | 372.62%8.44B | -32.03%7.4B | -15.89%9.37B | -28.66%22.76B | -113.13%-1.05B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -17.68%10.66B | 19.69%35.87B | 38.24%12.95B | 31.68%29.97B | 553.09%4.76B | 372.62%8.44B | -32.03%7.4B | -15.89%9.37B | -28.66%22.76B | -113.13%-1.05B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -15.03%4.86 | 22.31%16.17 | 38.23%5.72 | 33.00%13.22 | 577.27%2.1 | 363.75%3.71 | -31.01%3.27 | -14.57%4.138 | -28.24%9.94 | -112.67%-0.44 |
| Diluted earnings per share | -15.47%4.81 | 22.07%16.04 | 38.48%5.69 | 32.86%13.14 | 575.00%2.09 | 367.09%3.69 | -31.00%3.25 | -14.86%4.109 | -28.60%9.89 | -112.67%-0.44 |
| Dividend per share | 0 | 10.47%9.5 | 0 | 40.98%8.6 | 7.50%4.3 | 0 | 104.76%4.3 | 0 | 45.24%6.1 | 81.82%4 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |